Why the study?
Does inducible SERCA2a expression improve contractile dysfunction and abnormal calcium flux in mice with established diabetic cardiomyopathy?
Does inducible SERCA2a expression improve contractile dysfunction and abnormal calcium flux in mice with established diabetic cardiomyopathy?
Increasing SERCA2a expression reverses contractile dysfunction and abnormal calcium handling in established diabetic cardiomyopathy in a mouse model.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open translation of SERCA2a restoration beyond this mouse model.
Diabetic cardiomyopathy is characterized by reduced cardiac contractility independent of vascular disease. A contributor to contractile dysfunction in the diabetic heart is impaired sarcoplasmic reticulum function with reduced sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2a) pump activity, leading to disturbed intracellular calcium handling. It is currently unclear whether increasing SERCA2a activity in hearts with existing diabetic cardiomyopathy could still improve calcium flux and contractile performance. To test this hypothesis, we generated a cardiac-specific tetracycline-inducible double transgenic mouse, which allows for doxycycline (DOX)-based inducible SERCA2a expression in which DOX exposure turns on SERCA2a expression. Isolated cardiomyocytes and Langendorff perfused hearts from streptozotocin-induced diabetic mice were studied. Our results show that total SERCA2a protein levels were decreased in the diabetic mice by 60% compared with control. SERCA2a increased above control values in the diabetic mice after DOX. Dysfunctional contractility in the diabetic cardiomyocyte was restored to normal by induction of SERCA2a expression. Calcium transients from diabetic cardiomyocytes showed a delayed rate of diastolic calcium decay of 66%, which was reverted toward normal after SERCA2a expression induced by DOX. Global cardiac function assessed in the diabetic perfused heart showed diminished left ventricular pressure, rate of contraction, and relaxation. These parameters were returned to control values by SERCA2a expression. In conclusion, we have used mice allowing for inducible expression of SERCA2a and could demonstrate that increased expression of SERCA2a leads to improved cardiac function in mice with an already established diabetic cardiomyopathy in absence of detrimental effects.
No takes yet. Share an insight, caveat, or question.
Suárez et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: